---
title: "Ozempic (semaglutide) in type 2 diabetes: Specific populations questions"
description: "Specific populations questions on Ozempic (semaglutide) in type 2 diabetes, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: Does Ozempic need a dose adjustment for kidney or liver impairment? Is Ozempic safe and effective for adults 65 and older? Can Ozempic be used during pregnancy? Can patients breastfeed while taking Ozempic? 1 further question follow. 5 questions quoted from 4 sources."
canonical: "https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/specific-populations"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Ozempic (semaglutide) in type 2 diabetes: Specific populations questions

Manufacturer: Novo Nordisk Inc.  
Prescribing information: [Ozempic](https://www.novo-pi.com/ozempic.pdf), [Ozempic tablets](https://www.novo-pi.com/ozempictablets.pdf)

## Specific populations

<a id="ozempic-renal-hepatic-elderly"></a>

### Does Ozempic need a dose adjustment for kidney or liver impairment?

> “No dose adjustments recommended for patients with renal impairment<sup>1,2</sup>
>
> In patients with renal impairment, including kidney failure, no clinically relevant change in pharmacokinetics was observed
> The efficacy of semaglutide was not impacted by degree of renal function impairment
> Monitor renal function when initiating or escalating doses of Ozempic<sup>®</sup> in patients reporting severe adverse GI reactions”

Source: [OZEMPIC: Special Populations, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic/efficacy-safety/special-populations.html#:~:text=No%20dose%20adjustments%20recommended%20for%20patients,reporting%20severe%20adverse%20GI%20reactions)

> “No dose adjustments recommended for patients with hepatic impairment”

Source: [OZEMPIC: Special Populations, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic/efficacy-safety/special-populations.html#:~:text=No%20dose%20adjustments%20recommended%20for%20patients%20with%20hepatic)

<a id="ozempic-older-adults"></a>

### Is Ozempic safe and effective for adults 65 and older?

> “No dose adjustments recommended for patients aged ≥65 years<sup>1,2</sup>
>
> No overall differences in safety or efficacy were detected between patients aged 65 years and older and younger patients, but greater sensitivity of some older individuals cannot be ruled out”

Source: [OZEMPIC: Special Populations, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic/efficacy-safety/special-populations.html#:~:text=No%20dose%20adjustments%20recommended%20for%20patients%20aged,individuals%20cannot%20be%20ruled%20out)

<a id="ozempic-pregnancy"></a>

### Can Ozempic be used during pregnancy?

> “Pregnancy: Available data with semaglutide use in pregnant women are not sufficient to determine a drug associated risk for major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Discontinue Ozempic<sup>®</sup> in women at least 2 months before a planned pregnancy due to the long washout period for semaglutide”

Source: [OZEMPIC: GLP-1 RA for T2D, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic.html#:~:text=Pregnancy%3A%20Available%20data%20with%20semaglutide,long%20washout%20period%20for%20semaglutide)

> “OZEMPIC<sup>®</sup> should be used during pregnancy only if the potential benefit justifies the potential 
> risk to the fetus.”

Source: [OZEMPIC: Ozempic®, page 4, captured 2026-11-12](https://www.novo-pi.com/ozempic.pdf#page=4)

<a id="ozempic-breastfeeding"></a>

### Can patients breastfeed while taking Ozempic?

> “Lactation: A clinical lactation study reported semaglutide concentrations below the lower limit of quantification in human breast milk. However, salcaprozate sodium (SNAC) and/or its metabolites are present in human milk. Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC, an absorption enhancer for Ozempic<sup>®</sup> tablets, and because there are alternative formulations of semaglutide that do not contain SNAC that can be used during lactation, advise patients that breastfeeding is not recommended during treatment with Ozempic<sup>®</sup> tablets”

Source: [OZEMPIC: GLP-1 RA for T2D, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic.html#:~:text=Lactation%3A%20A%20clinical%20lactation%20study,tablets)

> “There are no data on the presence of semaglutide in human milk, the effects on the breastfed 
> infant, or the effects on milk production. Semaglutide was present in the milk of lactating rats, 
> however, due to species-specific differences in lactation physiology, the clinical relevance of 
> these data are not clear (see Data).”

Source: [OZEMPIC: Ozempic®, page 4, captured 2026-11-12](https://www.novo-pi.com/ozempic.pdf#page=4)

> “The developmental and health benefits of breastfeeding should”

Source: [OZEMPIC: Ozempic®, page 4, captured 2026-11-12](https://www.novo-pi.com/ozempic.pdf#page=4)

> “be considered along with the mother’s clinical need for OZEMPIC<sup>®</sup> and any potential adverse 
> effects on the breastfed infant from OZEMPIC<sup>®</sup> or from the underlying maternal condition.”

Source: [OZEMPIC: Ozempic®, page 4, captured 2026-11-12](https://www.novo-pi.com/ozempic.pdf#page=4)

Note: The breastfeeding recommendation in the first passage applies to Ozempic® tablets, which contain SNAC. The other passages are from section 8.2 of the Ozempic® injection Prescribing Information; its two-column layout splits the last sentence across the extracted page text, so it appears as two consecutive passages.

<a id="ozempic-children"></a>

### Can children or adolescents use Ozempic?

> “It is not known if Ozempic<sup>®</sup> is safe and effective for use in children.”

Source: [OZEMPIC: Information for Pharmacists, captured 2026-11-12](https://www.novomedlink.com/diabetes/products/treatments/ozempic/resources/for-pharmacists/pen.html#:~:text=It%20is%20not%20known%20if,effective%20for%20use%20in%20children.)

> “Safety and efficacy of OZEMPIC<sup>®</sup> have not been established in pediatric patients.”

Source: [OZEMPIC: Ozempic®, page 4, captured 2026-11-12](https://www.novo-pi.com/ozempic.pdf#page=4)

## Related pages
- [Medical information: Ozempic (semaglutide): Type 2 diabetes](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes)
- [Indication](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/safety)
- [Drug interactions](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/ozempic--type-2-diabetes/access-and-coverage)
